Comprehensive Stock Comparison
Compare Somnigroup International Inc (SGI) vs The Procter & Gamble Company (PG) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | SGI | 51.6% revenue growth vs PG's 0.3% |
| Value | PG | Lower P/E (24.0x vs 27.1x), PEG 4.30 vs 11.65 |
| Quality / Margins | PG | 19.3% net margin vs SGI's 5.1% |
| Stability / Safety | PG | Beta 0.12 vs SGI's 1.01, lower leverage |
| Dividends | PG | 2.4% yield, 36-year raise streak, vs SGI's 0.7% |
| Momentum (1Y) | SGI | +41.1% vs PG's -1.4% |
| Efficiency (ROA) | PG | 12.9% ROA vs SGI's 3.3%, ROIC 20.1% vs 9.1% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Valuation efficiency (growth/$)
Defensive / Recession hedge
Business Model
What each company does and how it makes money
SomniGroup International is a sleep technology and wellness company that develops science-backed products to enhance sleep quality and overall well-being. It generates revenue primarily from direct-to-consumer sales of smart sleep devices — including sleep trackers, smart pillows, and sleep environment controllers — supplemented by subscription services for personalized sleep coaching and data analytics. The company's competitive advantage lies in its proprietary sleep algorithms and integrated ecosystem that combines hardware, software, and behavioral science to create a comprehensive sleep improvement platform.
Procter & Gamble is a global consumer goods giant that sells everyday household products across beauty, grooming, health, fabric care, and baby care categories. It generates revenue primarily through product sales across its five main segments — Fabric & Home Care (~35% of sales), Baby & Family Care (~25%), Health Care (~15%), Beauty (~15%), and Grooming (~10%). Its competitive moat lies in its massive portfolio of iconic, trusted brands — like Tide, Pampers, and Gillette — that enjoy deep consumer loyalty and dominate retail shelf space worldwide.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
PG leads in 5 of 6 categories (Financial Metrics, Valuation Metrics). SGI leads in 1 (Total Returns).
Financial Metrics (TTM)
PG is the larger business by revenue, generating $85.3B annually — 11.4x SGI's $7.5B. PG is the more profitable business, keeping 19.3% of every revenue dollar as net income compared to SGI's 5.1%. On growth, SGI holds the edge at +54.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SGISomnigroup Intern… | PGThe Procter & Gam… |
|---|---|---|
| RevenueTrailing 12 months | $7.5B | $85.3B |
| EBITDAEarnings before interest/tax | $1.0B | $22.5B |
| Net IncomeAfter-tax profit | $384M | $16.5B |
| Free Cash FlowCash after capex | $633M | $14.8B |
| Gross MarginGross profit ÷ Revenue | +42.8% | +50.7% |
| Operating MarginEBIT ÷ Revenue | +10.2% | +23.6% |
| Net MarginNet income ÷ Revenue | +5.1% | +19.3% |
| FCF MarginFCF ÷ Revenue | +8.5% | +17.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +54.7% | +1.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +65.0% | -5.3% |
Valuation Metrics
At 25.7x trailing earnings, PG trades at a 47% valuation discount to SGI's 48.6x P/E. Adjusting for growth (PEG ratio), PG offers better value at 4.59x vs SGI's 20.90x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | SGISomnigroup Intern… | PGThe Procter & Gam… |
|---|---|---|
| Market CapShares × price | $18.8B | $388.5B |
| Enterprise ValueMkt cap + debt − cash | $26.9B | $414.4B |
| Trailing P/EPrice ÷ TTM EPS | 48.65x | 25.68x |
| Forward P/EPrice ÷ next-FY EPS est. | 27.11x | 24.01x |
| PEG RatioP/E ÷ EPS growth rate | 20.90x | 4.59x |
| EV / EBITDAEnterprise value multiple | 21.08x | 17.79x |
| Price / SalesMarket cap ÷ Revenue | 2.51x | 4.61x |
| Price / BookPrice ÷ Book value/share | 6.01x | 7.85x |
| Price / FCFMarket cap ÷ FCF | 29.67x | 27.66x |
Profitability & Efficiency
PG delivers a 30.9% return on equity — every $100 of shareholder capital generates $31 in annual profit, vs $12 for SGI. PG carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to SGI's 2.65x.
| Metric | SGISomnigroup Intern… | PGThe Procter & Gam… |
|---|---|---|
| ROE (TTM)Return on equity | +12.3% | +30.9% |
| ROA (TTM)Return on assets | +3.3% | +12.9% |
| ROICReturn on invested capital | +9.1% | +20.1% |
| ROCEReturn on capital employed | +13.1% | +23.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 2.65x | 0.68x |
| Net DebtTotal debt minus cash | $8.1B | $25.9B |
| Cash & Equiv.Liquid assets | $135M | $9.6B |
| Total DebtShort + long-term debt | $8.3B | $35.5B |
| Interest CoverageEBIT ÷ Interest expense | 2.79x | 52.82x |
Total Returns (with DRIP)
A $10,000 investment in SGI five years ago would be worth $26,334 today (with dividends reinvested), compared to $14,991 for PG. Over the past 12 months, SGI leads with a +41.1% total return vs PG's -1.4%. The 3-year compound annual growth rate (CAGR) favors SGI at 28.6% vs PG's 9.2% — a key indicator of consistent wealth creation.
| Metric | SGISomnigroup Intern… | PGThe Procter & Gam… |
|---|---|---|
| YTD ReturnYear-to-date | +0.9% | +18.6% |
| 1-Year ReturnPast 12 months | +41.1% | -1.4% |
| 3-Year ReturnCumulative with dividends | +112.8% | +30.3% |
| 5-Year ReturnCumulative with dividends | +163.3% | +49.9% |
| 10-Year ReturnCumulative with dividends | +536.5% | +150.1% |
| CAGR (3Y)Annualised 3-year return | +28.6% | +9.2% |
Risk & Volatility
PG is the less volatile stock with a 0.12 beta — it tends to amplify market swings less than SGI's 1.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | SGISomnigroup Intern… | PGThe Procter & Gam… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.01x | 0.12x |
| 52-Week HighHighest price in past year | $98.56 | $179.99 |
| 52-Week LowLowest price in past year | $53.10 | $137.62 |
| % of 52W HighCurrent price vs 52-week peak | +90.8% | +92.9% |
| RSI (14)Momentum oscillator 0–100 | 49.6 | 66.3 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 9.4M |
Analyst Outlook
Wall Street rates SGI as "Buy" and PG as "Buy". Consensus price targets imply 14.5% upside for SGI (target: $103) vs 0.3% for PG (target: $168). For income investors, PG offers the higher dividend yield at 2.41% vs SGI's 0.68%.
| Metric | SGISomnigroup Intern… | PGThe Procter & Gam… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $102.50 | $167.67 |
| # AnalystsCovering analysts | 9 | 51 |
| Dividend YieldAnnual dividend ÷ price | +0.7% | +2.4% |
| Dividend StreakConsecutive years of raises | 5 | 36 |
| Dividend / ShareAnnual DPS | $0.61 | $4.02 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | +1.7% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Mar 20 | Feb 26 | Change |
|---|---|---|---|
| Somnigroup Internat… (SGI) | 100 | 472.19 | +372.2% |
| The Procter & Gambl… (PG) | 100 | 128.13 | +28.1% |
Somnigroup Internat… (SGI) returned +163% over 5 years vs The Procter & Gambl… (PG)'s +50%. A $10,000 investment in SGI 5 years ago would be worth $26,334 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Somnigroup Internat… (SGI) | $533M | $7.5B | +1302.9% |
| The Procter & Gambl… (PG) | $65.3B | $84.3B | +29.1% |
Somnigroup International Inc's revenue grew from $533M (2016) to $7.5B (2025) — a 34.1% CAGR. The Procter & Gamble Company's revenue grew from $65.3B (2016) to $84.3B (2025) — a 2.9% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Somnigroup Internat… (SGI) | -2.1% | 5.1% | +344.9% |
| The Procter & Gambl… (PG) | 16.1% | 19.0% | +17.8% |
Somnigroup International Inc's net margin went from -2% (2016) to 5% (2025). The Procter & Gamble Company's net margin went from 16% (2016) to 19% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Somnigroup Internat… (SGI) | 16.5 | 48.5 | +193.9% |
| The Procter & Gambl… (PG) | 16.4 | 22 | +34.1% |
Somnigroup International Inc has traded in a 14x–49x P/E range over 6 years; current trailing P/E is ~49x. The Procter & Gamble Company has traded in a 16x–87x P/E range over 9 years; current trailing P/E is ~26x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Somnigroup Internat… (SGI) | -0.31 | 1.84 | +693.5% |
| The Procter & Gambl… (PG) | 3.69 | 6.51 | +76.4% |
Somnigroup International Inc's EPS grew from $-0.31 (2016) to $1.84 (2025). The Procter & Gamble Company's EPS grew from $3.69 (2016) to $6.51 (2025) — a 7% CAGR.
Chart 6Free Cash Flow — 5 Years
Somnigroup International Inc generated $633M FCF in 2025 (+6% vs 2021). The Procter & Gamble Company generated $14B FCF in 2025 (-10% vs 2021).
SGI vs PG: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is SGI or PG a better buy right now?
The Procter & Gamble Company (PG) offers the better valuation at 25.7x trailing P/E (24.0x forward), making it the more compelling value choice. Analysts rate Somnigroup International Inc (SGI) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SGI or PG?
On trailing P/E, The Procter & Gamble Company (PG) is the cheapest at 25.7x versus Somnigroup International Inc at 48.6x. On forward P/E, The Procter & Gamble Company is actually cheaper at 24.0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Procter & Gamble Company wins at 4.30x versus Somnigroup International Inc's 11.65x.
03Which is the better long-term investment — SGI or PG?
Over the past 5 years, Somnigroup International Inc (SGI) delivered a total return of +163.3%, compared to +49.9% for The Procter & Gamble Company (PG). A $10,000 investment in SGI five years ago would be worth approximately $26K today (assuming dividends reinvested). Over 10 years, the gap is even starker: SGI returned +536.5% versus PG's +150.1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SGI or PG?
By beta (market sensitivity over 5 years), The Procter & Gamble Company (PG) is the lower-risk stock at 0.12β versus Somnigroup International Inc's 1.01β — meaning SGI is approximately 751% more volatile than PG relative to the S&P 500. On balance sheet safety, The Procter & Gamble Company (PG) carries a lower debt/equity ratio of 68% versus 3% for Somnigroup International Inc — giving it more financial flexibility in a downturn.
05Which has better profit margins — SGI or PG?
The Procter & Gamble Company (PG) is the more profitable company, earning 19.0% net margin versus 5.1% for Somnigroup International Inc — meaning it keeps 19.0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24.3% versus 13.2% for SGI. At the gross margin level — before operating expenses — PG leads at 51.2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is SGI or PG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential. By this metric, The Procter & Gamble Company (PG) is the more undervalued stock at a PEG of 4.30x versus Somnigroup International Inc's 11.65x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, The Procter & Gamble Company (PG) trades at 24.0x forward P/E versus 27.1x for Somnigroup International Inc — 3.1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SGI: 14.5% to $102.50.
07Which pays a better dividend — SGI or PG?
All stocks in this comparison pay dividends. The Procter & Gamble Company (PG) offers the highest yield at 2.4%, versus 0.7% for Somnigroup International Inc (SGI).
08Is SGI or PG better for a retirement portfolio?
For long-horizon retirement investors, The Procter & Gamble Company (PG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.12), 2.4% yield, +150.1% 10Y return). Both have compounded well over 10 years (PG: +150.1%, SGI: +536.5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between SGI and PG?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.